Tegaserod
RxNorm 139778
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 139778 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tegaserod.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing tegaserod (medicinal product)
(Atom ID: 10319144)
INPrescribable
Ingredient (IN):
Tegaserod
(Atom ID: 939154)
PTPrescribable
Designated preferred name (PT):
Tegaserod
(Atom ID: 2358819)
FNPrescribable
Full form of descriptor (FN):
Tegaserod (substance)
(Atom ID: 2358820)
PTPrescribable
Designated preferred name (PT):
Tegaserod-containing product
(Atom ID: 10821554)
Patient Education
Tegaserod
Tegaserod is used in women younger than 65 years of age to treat irritable bowel syndrome with constipation (IBS-C; a condition that causes stomach pain or cramps, bloating, and infrequent or difficult passage of stools). Tegaserod is in a class of medications called serotonin agonists. It works by improving muscle movement and increasing production of fluid in the bowels.
[Learn More]
* Please review the disclaimer below.